COMMUNIQUÉS West-GlobeNewswire

Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives

05/08/2019 - 15:05

WESTLAKE VILLAGE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that the Company has retained Cowen as an [...]

INmune Bio Reports Positive Preliminary Data from INB03 Phase I Clinical Trial in Cancer

05/08/2019 - 15:01

LA JOLLA, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, reported [...]

Denali Therapeutics Announces That Its Partner Sanofi has Commenced Dosing of DNL758 in a Phase 1 Study

05/08/2019 - 15:00

Sanofi has commenced dosing of DNL758 in a Phase 1 healthy volunteer study. DNL758 is an investigational small molecule RIPK1 inhibitor that does not cross the blood-brain barrier, and is intended for peripheral [...]

Rafael Pharmaceuticals Launches Clinical Trial Web Portal “Rafael Trial Connect”

05/08/2019 - 15:00

Newark, NJ, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today the launch of Rafael Trial [...]

Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update

05/08/2019 - 15:00

SAN DIEGO, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”), a specialty biopharmaceutical company primarily focused on developing and commercializing products in the [...]

MannKind and One Drop Sign Collaboration Agreement to Integrate Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform

05/08/2019 - 15:00

WESTLAKE VILLAGE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) and One Drop today announced that they have signed a collaborative agreement that is intended to integrate MannKind’s [...]

Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference

05/08/2019 - 15:00

SAN DIEGO, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]

CeCors, Inc. to Acquire 100% of Medical Records and Data Company

05/08/2019 - 15:00

LAS VEGAS, NV, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK:CEOS) ; a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is pleased to update [...]

Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development

05/08/2019 - 15:00

Company Plans to Advance its Phase I Cancer Immunotherapy StemVacs™ to US Patients OCEANSIDE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Therapeutics Solutions International, Inc., ( OTC Markets: TSOI [...]

Brazil Issues Vystar Patent Notice of Allowance for Deproteinization of Vytex Natural Rubber Latex

05/08/2019 - 14:36

WORCESTER, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) has received a notice of allowance from Brazil for a patent titled “Natural Rubber Latex Having Reduced Allergenicity and Method of [...]

Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat

05/08/2019 - 13:50

Studies highlight antimicrobial activity for AC5 technology platform; AC5™ Topical Hemostat 1 under Review by Notified Body FRAMINGHAM, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (" [...]

Novo Nordisk A/S – Share repurchase programme

05/08/2019 - 13:41

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 5 August 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]

Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates

05/08/2019 - 13:30

During the Second Quarter, Minerva announced several important clinical advancements, including positive top line results from two Phase 2b studies of seltorexant (MIN-202) in major depressive disorder (MDD) and [...]

Alkahest Announces Positive Top-line Data from Phase 2 Study in Mild to Moderate Alzheimer’s Disease

05/08/2019 - 13:30

SAN CARLOS, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced top-line data [...]

VIVUS Announces Approval of Qsymia® in the Republic of Korea

05/08/2019 - 13:30

VIVUS receives $2.5 million milestone payment CAMPBELL, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that its Korean marketing partner [...]

Kiniksa Pharmaceuticals Announces Collaboration with the Myocarditis Foundation for the Pericarditis Community

05/08/2019 - 13:30

HAMILTON, Bermuda, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]

Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA

05/08/2019 - 13:30

Agreement reached with FDA on submission of additional non-clinical information for NDA review of lumateperone for the treatment of schizophrenia Lumateperone PDUFA goal date extended three months to December 27, 2019 [...]

Theratechnologies’ CFO to Attend 39ᵗʰ Annual Growth Conference Held by Canaccord Genuity in Boston

05/08/2019 - 13:30

MONTREAL, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend the 39 th [...]

Le chef de la direction financière de Theratechnologies assistera à la 39ᵉ Annual Growth Conference tenue par Canaccord Genuity à Boston

05/08/2019 - 13:30

MONTRÉAL, 05 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président sénior et chef de la direction financière assistera à la 39 e [...]